The Bloodline with LLS

Living with chronic lymphocytic leukemia (CLL) can be a challenging journey for both patients and caregivers.  

However, there is a beacon of hope. Tune in to our latest episode, where we speak to Dr. Mayur Narkhede of the University of Alabama about groundbreaking research and innovative treatments for CLL. Discover the potential of CAR T-cell therapy, bispecific antibodies and other cutting-edge options that bring the promise of new hope and possibilities for those affected by CLL. Don’t miss this inspiring and informative discussion! 

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, Inc.

The post Hope on the Horizon: Chronic Lymphocytic Leukemia first appeared on The Bloodline with LLS.

Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope!

Join us as Dr. Eric Padron of Moffitt Cancer Center and Dr. Lee Greenberger of The Leukemia & Lymphoma Society unveil the groundbreaking new CMML Initiative, fueled by recent funding aimed at revolutionizing treatment. Discover how this initiative is paving the way for individualized therapies that promise to enhance the quality of life for CMML patients and bring us closer to a cure.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Taiho Oncology, Inc.

The post Advancing the Science: Chronic Myelomonocytic Leukemia (CMML) first appeared on The Bloodline with LLS.

The treatment landscape for non-Hodgkin lymphoma has significantly evolved over the past few decades. With groundbreaking advancements in CAR T-cell therapy and bispecific antibodies, researchers are making strides toward curative treatments and enhancing patients’ quality of life.

In this episode, we speak with Dr. David Bond from The Ohio State University about the latest developments in treating both aggressive and slow-growing non-Hodgkin lymphomas. He discusses innovative, newly approved therapies for patients, as well as how improvements in supportive care better manage the physical and emotional side effects of treatment.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, Inc.

The post Innovative Therapies: Transforming Non-Hodgkin Lymphoma Care first appeared on The Bloodline with LLS.

Exercise, or simply moving the body, can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park Comprehensive Cancer Center and blood cancer survivors, Paul Rothweiler and Joe Grey, share about a clinical trial they developed to introduce a personalized strength training program to patients and caregivers.

Dr. Holtan highlights the benefits of strength training for all patients, while Paul and Joe share how exercise has aided their physical and emotional recovery during and after their treatments. For patients and survivors who may be fearful or nervous about starting an exercise program, this episode is for you!

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by Genentech, Inc.

The post Exercise and Cancer: Celebration That You CAN first appeared on The Bloodline with LLS.

For patients with chronic blood cancers, such as Waldenström Macroglobulinemia (WM), quality of life is a main priority. Physical and emotional side effects of the disease or treatment may present several challenges for patients and caregivers.  

In this episode, we were onsite at the International Waldenström‘s Macroglobulinemia Foundation’s 2024 IWMF Educational Forum in Renton, WA.  Elissa met with experts who discussed how integrative oncology, wellness, mental health, and peripheral neuropathy affects WM patients and their caregivers.

While this episode focuses on WM, the topics discussed are relevant to all types of cancer. We encourage you to listen and learn! 

Mentioned on this episode: 

Additional LLS Support Resources: 

The post LIVE! At IWMF: Living with Waldenström Macroglobulinemia first appeared on The Bloodline with LLS.

Explore the cutting-edge of oncology as we delve into the revolutionary world of CAR T-cell therapy, a more recent medical advancement in the fight against blood cancer.  

Join our conversation with Dr. Marco Davila of Roswell Park Comprehensive Cancer Center in Buffalo, NY, as he highlights the significant impact CAR T-cell therapy has made on treating various blood cancers. Dr. Davila discusses the current uses of this therapy and gives us a look at the ongoing clinical trials that are broadening the horizons of this innovative treatment. 

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; Kite, a Gilead Company; and Novartis Pharmaceuticals Corp.

The post Cellular Revolution: CAR T-cell Therapy first appeared on The Bloodline with LLS.

In this episode, we speak with Dr. Matthew Matasar of Rutgers Cancer Institute, and Elizabeth Stone, who was diagnosed with Hodgkin lymphoma in 2012. 

Dr. Matasar discusses the current and emerging treatments for Hodgkin lymphoma. Elizabeth shares her story of resilience as a refractory patient throughout multiple treatments, and how she has navigated a life of hardships, joy, love and friendship while in a highly immunocompromised state.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by Affimed Inc.

The post Patient-Doctor Perspectives: Resilience in Relapsed/Refractory Hodgkin Lymphoma first appeared on The Bloodline with LLS.

Unase a nosotros en nuestra conversación con Ricardo Lopez, Dietista Oncológico. En este episodio él nos explicará la importancia de tener una nutrición adecuada antes, durante y después de un tratamiento, y nos proveerá consejos para aliviar efectos secundarios causado por el cáncer.

Mencionado en este episodio:

Temas y recursos de LLS:

The post La Nutrición y el Cáncer first appeared on The Bloodline with LLS.

In this episode, we speak to a myeloma patient and her teenage daughter about the impact that myeloma had on her family. Lynn Steele, a social worker and Information Specialist at LLS, then joins us to share tips and resources on how families can navigate a cancer diagnosis together. 

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by: AbbVie Inc.; Genentech, Inc. & Biogen; and Johnson & Johnson.

The post Family Ties: Navigating Multiple Myeloma Together first appeared on The Bloodline with LLS.

In this episode, Dr. Sharon Castellino, a pediatric oncologist at Children’s Healthcare of Atlanta, examines the impact of healthcare equity and barriers to care for patients and caregivers dealing with blood cancer.

Dr. Castellino sheds light on how groundbreaking treatments have transformed the landscape of cancer care, emphasizing the crucial role that LLS, patient advocates and government entities can play in ensuring accessible and quality care for all.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by: Genentech, Inc. & Biogen and Merck & Co., Inc.

The post Bridging the Gaps: Striving for Accessible Cancer Care first appeared on The Bloodline with LLS.